Parkinson Disease study: DBS On vs DBS Off
Official title Theta Deep Brain Stimulation for Cognitive Enhancement in Parkinson's Disease
ClinicalTrials.gov ID: NCT06518824
What this study is testing
- What it's testing
- This study aims to find out if using a specific frequency of electrical stimulation in the brain can improve executive control, which is the ability to plan and focus.
- Who it's for
- People who have Parkinson's disease and are experiencing cognitive impairment, or trouble with thinking and memory.
- What's involved
- Participants will receive deep brain stimulation, which involves sending electrical signals to a specific part of the brain, to see if it helps with cognitive tasks.
- Time commitment
- The source text does not specify the duration of the study or the number of visits required.
Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 80
You may be able to join if
- Those with STN DBS devices
- Those with pre- and post-operative imaging
- Those that are at least 3 months post-operative
You likely can't join if
- Those unable to complete the cognitive task (due to language barriers or dementia)
- Those with significant DBS complications
The study team makes the final eligibility decision.
Where it is enrolling
- Vancouver, British Columbia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Vancouver, British Columbia, Canada. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.